PAVmed Inc.
PAVM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $3 | $4 | $0 | $0 |
| + Debt | $9 | $9 | $0 | $0 |
| Enterprise Value | $6 | $5 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -16.7% | -25% | -20% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,000% | -583.3% | -887.5% | -380% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -119,620% | -204,966.7% | 233,375% | 12,180% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -107,660% | -198,683.3% | 237,100% | 14,310% |
| EPS Diluted | -0.29 | -0.74 | 0.337 | 0.12 |
| % Growth | 60.8% | -319.5% | 180.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |